Market Overview

Argus Cites Disappointing Organic Growth In Procter & Gamble Downgrade

Argus Cites Disappointing Organic Growth In Procter & Gamble Downgrade
Related PG
Navigating The Maze Of The Cannabis Market After The Daze Of Summer
Benzinga's Top Upgrades, Downgrades For September 20, 2018
'Safer' Dividend Aristocrats See 8.9% To 19.8% Gains Per September Stockbroker Sums (Seeking Alpha)

Procter & Gamble Co (NYSE: PG) reported fiscal third-quarter earnings Thursday that exceeded the Street's expectations but also reaffirmed disappointing organic growth rates, according to Argus.

The Analyst

Argus' John Staszak downgraded Procter & Gamble's stock rating from Buy to Hold.

The Thesis

Procter & Gamble has overseen multiple transactions over the years to help reinvigorate organic growth, Staszak said in the Friday downgrade note. (See the analyst's track record here.) 

The company pledged in 2014 to divest or sell more than half its brands, the analyst said. Notable transactions have included the sale of its beauty business, the Duracell brand, the Hipoglos business and others. 

Procter & Gamble's organic growth hasn't sufficiently improved to satisfy expectations, Staszak said. The company not only continues to lose market share in multiple categories, but the margin improvement seen in recent years has slowed, he said. 

Procter & Gamble guided its fiscal 2018 organic revenue growth to come in at the low end of its prior 2-3-percent guidance range, Staszak said. The company faces ongoing risks from rising commodity costs, which can cut into margins when combined with lower prices in stores, according to Argus.

Notable investments in new products like Tide PODS could also hurt Procter & Gamble's financials if the items fail to live up to consumer expectations, Staszak said. 

Based on the multiple challenges over the past year and the high level of competition, the stock is "fairly valued" at its current 17.7x multiple on the analyst's 2018 EPS estimate, in Argu's view. If Procter & Gamble is able to accelerate its organic growth, a bullish stance on the stock would then be justified, Staszak said. 

Price Action

Shares of Procter & Gamble were trading lower by nearly 0.2 percent at $74.81 at the time of publication Friday. 

Related Links:

2 Sell-Side Reactions To The Nelson Peltz-Procter & Gamble Proxy Play

Stock Market Seems Directionless, Volatility Low As Investors Await News

Photo courtesy of Procter & Gamble.

Latest Ratings for PG

Sep 2018Atlantic EquitiesInitiates Coverage OnOverweight
Aug 2018Deutsche BankMaintainsHoldHold
Aug 2018Deutsche BankMaintainsHoldHold

View More Analyst Ratings for PG
View the Latest Analyst Ratings

Posted-In: Argus Beauty Duracell Hipogols John StaszakAnalyst Color Downgrades Analyst Ratings Best of Benzinga


Related Articles (PG)

View Comments and Join the Discussion!

GE, Honeywell Issue Positive Tidings To Keep Earnings Parade Rolling On

Bitcoin Cash Price Analysis: BCH/USD Making Higher Consolidations Above $950, Looming Upside Breakout Toward $1,000